CLL, REFRACTORY

Clinical trials for CLL, REFRACTORY explained in plain language.

Never miss a new study

Get alerted when new CLL, REFRACTORY trials appear

Sign up with your email to follow new studies for CLL, REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 2

New hope for Tough-to-Treat leukemia: phase 3 trial pits rocbrutinib against pirtobrutinib

Disease control Recruiting now

This study tests a new drug, rocbrutinib, against another drug, pirtobrutinib, in people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or not responded to prior treatments. About 306 adults will take one of the two pills daily to s…

Matched conditions: CLL, REFRACTORY

Phase: PHASE3 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control

Last updated May 11, 2026 20:51 UTC

CLL, REFRACTORY

Get alerted when new CLL, REFRACTORY trials appear

New hope for Tough-to-Treat leukemia: phase 3 trial pits rocbrutinib against pirtobrutinib